Impact of Marrow Transplantation in Acute Myeloid Leukemia in First Complete Remission: Experience from MRC AML-10 TrialA total of 1900 patients under 56 years of age were entered into the Medical Research Council (MRC) AML-10 trial, which aimed to compare the induction schedules, and the ...
This report describes the results of a study of central nervous system (CNS) prophylaxis and combination chemotherapy for the maintenance of remission in adult acute lymphoblastic leukemia. Adults with acute lymphoblastic leukemia who achieved complete remission were treated with 2,400 rads cranial irradi...
Allogeneic Hematopoietic Stem Cell Transplantation Improves Outcome of Patients > 60 Years with Acute Myeloid Leukemia in First Complete Remission: A 10-Year Single Center Transplantation Program Analysis 来自 学术范 喜欢 0 阅读量: 9 作者:
We performed a decision analysis comparing allogeneic hematopoietic cell transplantation (allo-HCT) versus chemotherapy in first complete remission for patients with cytogenetically intermediate-risk acute myeloid leukemia, depending on the presence or absence of FLT3-internal tandem duplication (ITD), nucleo...
Martinelli G, Ottaviani E, Testoni N, Visani G, Terragna C, Amabile M, et al. Molecular remission in PCR-positive acute myeloid leukemia patients with inv(16): role of bone marrow transplantation procedures. Bone Marrow Trans- plant 1999;24:694-7....
Cheuk, D. Inherent problems of comparing second and third remission in patients with acute lymphoblastic leukemia. Bone Marrow Transplant 46, 1570 (2011). https://doi.org/10.1038/bmt.2010.333 Download citation Published17 January 2011 Issue DateDecember 2011 DOIhttps://doi.org/10.1038/bmt.2010.333...
3: Mobilization of Normal Mouse Progenitors and Acute Promyelocytic Leukemia (APL) Cells With Inhibitors of CXCR4 and VLA-4 in Splenectomized and Unsplenectomized Mice Biology of Blood and Marrow Transplantation, Volume 14, Issue 2, Supplement, February 2008, Pages 1–2 PDF (60 K) View mo...
Indications for allogeneic hematopoietic cell transplantation for adults with Philadelphia-chromosome negative acute lymphoblastic leukemia in first complete remission: all about MRD? Ibrahim Aldoss & Vinod Pullarkat Bone Marrow Transplantation volume 54, pages 3–5 (2019)Cite this article 1458 Accesses...
We report on the clinical outcomes of a group of 701 adults aged ≥70 years, with acute myeloid leukemia (AML) in first complete remission (CR1), who received a first HCT, from HLA-matched sibling donors (MSD), 10/10 HLA-matched unrelated donors (UD), 9/10 HLA-mismatched unrelated ...
Fourteen patients with high-risk T-lineage acute lymphoblastic leukemia (ALL) in complete remission underwent autologous bone marrow transplantation (BMT) in an attempt to eradicate their residual disease burden. A combined immunochemotherapy protocol using a cocktail of two immunotoxins directed against ...